Skip to main content
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
As of Mar 23
Business1 sourcesNeutral

Tessera Therapeutics Receives Grant To Advance In Vivo Gene Writing Approaches Towards A Potential Human Immunodeficiency Virus (HIV) Cure

(MENAFN - GlobeNewsWire - Nasdaq) Funding from the Gates Foundation supports development of multiple in vivo Gene Writing strategies aimed at enabling a scalable cure for HIVSOMERVILLE, Mass., March ...

Menafn
via Menafn
ShareRead original

Read the full article at Menafn →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Menafn
Menafn
NewsData

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
ME Group International Plc Reports Advance In Full Year Income
Next
USA Rare Earth And Arnold Magnetic Technologies Partner To Expand U.S.-Made Rare Earth Magnet Supply For Critical Industries

Related Articles

GMEX Robotics Stock Gains 32% Over AU$4.2 Mln Contract From Leading Australian Food & Beverage GroupBusiness
GMEX Robotics Stock Gains 32% Over AU$4.2 Mln Contract From Leading Australian Food & Beverage Group
Unknown-7h ago-1 sources
NagaCorp Ltd. Announces Climb In Full Year ProfitBusiness
NagaCorp Ltd. Announces Climb In Full Year Profit
Unknown-10h ago-1 sources
BOE Varitronix Limited Full Year Profit DeclinesBusiness
BOE Varitronix Limited Full Year Profit Declines
Unknown-10h ago-1 sources